Summary of KDIGO 2024: Latest Updates on the Efficacy and Safety of Budesonide in Treating IgA Nephropathy

CPE point : 1 per event

This is an in-service training for the CUHK Medical Centre staff

Learning objectives:

Upon completion of the activity, participants will learn:

Objective 1: Update on Clinical Information of IgA Nephropathy

Objective 2: Understanding the Mechanism of Targeted Therapy Based on 4-Hit Pathogenesis

Objective 3: Practical Use of Nefecon Therapy

Objective 4: Application of KDIGO Guidelines in Clinical Practice

 

Date:
2025-04-07
Time:
1:00pm to 2:00pm
Venue:
L3 Pharmacy Library, CUHKMC
Organising Institute:
CUHK Medical Centre
Speaker:
Pinky Yuen Ping Hon, - Regional Senior Medical Affairs Manager at Everest Medicines




Related CPE Activities: